Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?

With no drugs currently approved for treatment and cure of COVID-19 (coronavirus disease 2019), hydroxychloroquine is one of the many first-line drugs used in the management. However, given the life-threatening adverse effects of HCQ that have been reported, its use as a prophylactic treatment remai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:SN Compr Clin Med
Hlavní autoři: Thangaraju, Pugazhenthan, Venkatesan, Nanditha, Venkatesan, Sajitha, Gurunthalingam, Meenalotchini Prakash, Thangaraju, Eswaran
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2020
Témata:
Covid-19
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7351559/
https://ncbi.nlm.nih.gov/pubmed/32838163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s42399-020-00392-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky